CVCs Versus Midline Catheters

Part of paid clinical trials in The Bronx, New York.

Sponsor
Albert Einstein College of Medicine
Study ID
NCT06884176
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Central Venous Catheter
  • Complication of Catheter
  • Midline Catheter

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Ultrasound Guided Central Venous Catheter — DEVICE
    Patients randomized to this arm will receive an ultrasound guided central venous catheter. The catheter is 20cm in length.
  • Ultrasound Guided Midline Catheter — DEVICE
    Patients randomized to this arm will receive an ultrasound guided midline catheter. The catheter is 8-10cm in length.

Study Details

The goal of this clinical trial is to learn if midline catheters can reduce adverse patient outcomes in adult patients requiring a single vasopressor. The main questions the study aims to answer are: * Do midline catheters reduce the rates of catheter-related bloodstream infections as compared to central venous catheters? * Do midline catheters reduce the rates of deep venous thrombosis as compared to central venous catheters? Researchers will compare midline catheters to central venous catheters to see if there is a reduction in these events. Participants will be randomized to the midline catheter group or the central venous catheter group. The catheters will be part of standard of care for vasopressor therapy. The participants will be followed for 30 days.

Key Dates

Start date
Jun 30, 2026
Status verified
Apr 2026
Primary completion
Jun 30, 2027
Completion
Jun 30, 2027

Study Design

Enrollment
100 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Active Comparator: central venous catheter
    If randomized to this group, patients will receive a triple lumen central venous catheter
  • Active Comparator: Midline catheter
    If randomized to this group, patients will receive a single lumen midline catheter

Primary Outcome Measure

Number of catheter related bloodstream infections (CRBSI) within 28 days of placement [ Time Frame: Up to 28 days from placement of catheter ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Jacobi Medical CenterThe BronxNew York10461
Ariella Gartenberg, MD
[email protected]
201-787-1762
Sandeep Dhillon, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in The Bronx, NY

By research site
Jacobi Medical Center· The Bronx, NY

Related Studies